Brief: Vistin Pharma Q1 Net Profit Of NOK 21.5 Mln
24/04/2026 06:45
April 24 (Reuters) - Vistin Pharma ASA VISTN.OL: Q1 REVENUE OF MNOK 112 AND EBITDA OF MNOK 27 Q1 NET PROFIT OF MNOK 21.5 PROPOSES ORDINARY CASH DIVIDEND OF UP TO NOK 1.50 PER SHARE IS CURRENTLY NOT AFFECTED BY MIDDLE EAST HORMUZ SITUATION DUE TO BUILD UP OF SIGNIFICANT SAFETY STOCK OF CRITICAL RAW MATERIALS DURING PAST QUARTERS INCREASED FREIGHT AND RAW MATERIAL PRICES ARE EXPECTED GOING FORWARD Source text: ID:nGNE4JRktD Further company coverage: VISTN.OL (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))